286 Results (Page 10 of 12)
Middle East Markets Research Reports
Mexico Human Papillomavirus (HPV) Vaccine Market Analysis
Mexico Human Papillomavirus (HPV) vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for HPV vaccines is mainly being driven by the rising need for prevention of these infections as well as the rising prevalence of human papillomavirus (HPV)-related malignancies of the anus, vulva, vagina, penis, and oropharynx. Some of the key players in this market are Xenetic Biosciences, Inc., Bharat Biotech., AstraZeneca, GlaxoSmithKline plc., Johnson & Johnson, Serum Institute of India Pvt. Ltd, Inovio Pharmaceuticals, Inc, Novartis AG, Sanofi, Merck & Co., Inc.
Mexico Human Rotavirus Vaccine Market Analysis
Mexico human rotavirus vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing global supply of goods to comply with and meet the demands of immunisation strategies to eradicate endemic diseases is one of the major reasons boosting market expansion. Globally, there is more government control to ensure that everyone has access to low- or no-cost immunizations. All these factors will drive the growth of human rotavirus vaccine market. Some of the key players in this market are GlaxoSmithKline plc. (UK), Sanofi (France), Pfizer Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Emergent BioSolutions, Inc. (US), CSL Limited (Australia), Inovio Pharmaceuticals, Inc. (US), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan).
Mexico Immune Checkpoint Inhibitors Market Analysis
Mexico immune checkpoint inhibitors market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for immune checkpoint inhibitors is expanding as a result of factors such as leading an unhealthy lifestyle, a rise in cancer incidence, and genetic mutation and alteration that have an impact on how much the nation's healthcare systems cost. Some of the global key players in this market are AstraZeneca PLC, Eli Lilly and Company (ARMO Biosciences.), Bristol-Myers Squibb Company, Roche Holding AG, Incyte Corporation, Novartis AG, etc.
Mexico Immunosuppressant Drugs Market Analysis
Mexico immunosuppressant drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The key factor fueling the growth of the immunosuppressants market is the rise in autoimmune illnesses like multiple sclerosis, alopecia areata, and arthritis. The market growth for immunosuppressants is also influenced by an increase in organ transplant procedures, such as kidney and liver transplants, which is brought on by an increase in the incidence of organ failure. Some of the major key players are Intas Pharmaceuticals Ltd. (Accord Healthcare Ltd.), Mylan N.V., AbbVie Inc., Sanofi S.A., GlaxoSmithKline Plc., Astellas Pharma Inc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer Inc., Novartis International AG (Sandoz), Bristol-Myers Squibb Company.
Mexico Infection Control Supplies Market Analysis
Mexico infection control supplies market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The key drivers driving the infection control sector are the expanding number of procedures that call for control measures to stop spreading and the increased prevalence of nosocomial infections. The key players in this market are 3M Company, Belimed AG, Halyard Health, Inc., Getinge Group, Advanced Sterilization Products, Matchana Group, Sterigenics International, MMM Group, Cantel Medical Corporation, STERIS Corporation.
Mexico Infectious Wound Care Management Market Analysis
Mexico infectious wound care management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expanding as a result of the ageing population, the prevalence of chronic diseases, and technologically advanced and lifestyle-related wound care products. The key players in this market are Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp, Medtronic, 3M, Derma Sciences Inc. (Integra LifeSciences), Medline Industries, Advancis Medical, B. Braun Melsungen AG.
Mexico Inflammatory Bowel Disease (IBD) Drugs Market Analysis
Mexico Inflammatory Bowel Disease (IBD) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Numerous variables, including genetic predisposition, environmental triggers, and immune system disturbance, are to blame for the rising prevalence of ulcerative colitis and Crohn's disease. Most people who have ulcerative colitis or Crohn's disease have a family history of the condition. This will act as a driver for Inflammatory Bowel Disease (IBD) drugs market. AbbVie Inc. (U.S.) Takeda Pharmaceutical Company Limited (Tokyo) UCB S.A. (Belgium) Bausch Health Companies Inc. (Canada) Bristol-Myers Squibb Company (U.S.) Pfizer Inc. (U.S.) Celltrion Inc. (South Korea) Johnson & Johnson Services, Inc. (U.S.) are the top key players operating in this market.
Middle East Radiotherapy Market Analysis
This report presents a strategic analysis of the Middle East Radiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Radiotherapy Market, offering unmatched value, accuracy, and expert insights.
Middle East Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Middle East Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy, and expert insights.
Middle East Diabetes Drugs Market Analysis
Middle East diabetes drugs market size was valued at $2.47 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.10 % from 2022-30 and will reach $4.27 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Middle East diabetes drug market will grow as patients become more aware of the importance of managing their diabetes. The key market players are Gulf Pharmaceutical Industries (UAE), Neopharma (UAE), Tabuk Pharmaceuticals (SAU), Pharaonia Pharmaceuticals (EGY), and others.
Middle East Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Middle East Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Depression Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Middle East Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of the Middle East Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
Middle East Bioinformatics Market Analysis
Middle East Bioinformatics market is projected to grow from $614 Mn in 2022 to $2200.66 Mn by 2030, registering a CAGR of 17.30% during the forecast period of 2022-30. The main factors driving the growth would be a decrease in the cost of genetic sequencing per base and the growing need for precision medicine. The market is segmented by technology and by application. Some of the major players include G42 Healthcare, IBM Life Sciences, Agilent Technologies, Qiagen, and Thermo Fisher Scientific.
Middle East Antiviral Drugs Market Analysis
This report presents a strategic analysis of the Middle East Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East Antiviral Drugs Market, offering unmatched value, accuracy, and expert insights.
Middle East Anti Aging Therapeutics Market Analysis
This report presents a strategic analysis of the Middle East Anti-Aging Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East's aging Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Middle East 3D Printing Medical Devices Market Analysis
This report presents a strategic analysis of the Middle East 3D Printing Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East 3D Printing Medical Devices Market, offering unmatched value, accuracy, and expert insights.
Middle East 3D Imaging Market Analysis
This report presents a strategic analysis of the Middle East 3D Imaging Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East 3D Imaging Market, offering unmatched value, accuracy, and expert insights.
Middle East Alexipharmic Drugs Market Analysis
Middle East Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 5.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The Middle East Alexipharmic Drugs market will grow significant investments in healthcare infrastructure, such as hospitals, clinics, and medical centers. This has led to an increase in the availability of alexipharmic drugs and improved access to healthcare services for the population. The key market players are Gulf Pharmaceutical Industries (UAE), Tabuk Pharmaceuticals (SAU), Hikma Pharmaceuticals, and others.
Middle East Anemia Drugs Market Analysis
The Middle East Anemia drugs market was valued at $639 Mn in 2022 and is estimated to expand at a CAGR of 9.9% from 2022-30 and will reach $1360 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Vifor Pharma, Amgen, Roche, Novartis, Takeda Pharmaceutical, Eli Lilly and Company, Sanofi
Middle East ePharmacy Market Analysis
This report presents a strategic analysis of the Middle East ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Middle East ePharmacy Market, offering unmatched value, accuracy, and expert insights.
Middle East Alzheimer’s Disease Drugs Market Analysis
Middle East Alzheimer’s Disease Drugs market was valued at $617 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $1267 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and government initiatives. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Johnson and Johnson, Lupin Limited, Biogen Inc, Pfizer Inc, F. Hoffmann-La Roche AG, Novartis AG, Allergan Plc (acquired by Abbvie), Amarantus Bioscience Holdings Inc, and GE Healthcare.
Middle East Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Middle East Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.
Middle East Oncology Drugs Market Analysis
This report presents a strategic analysis of the Middle East Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
Middle East Digital Health Market Analysis
This report presents a strategic analysis of the Middle East Digital Health Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Digital Health Market, offering unmatched value, accuracy and expert insights.
Middle East Anti-Depressants Drugs Market Analysis
The Middle East Anti-Depressants drugs market size was valued at $3.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $4.64 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, and distribution channel. The Middle East Anti-Depressants drug market will grow because Depression is a common mental health disorder in the Middle East, affecting a significant portion of the population. The key market players are GlaxoSmithKline plc (GBR), AstraZeneca (GBR), Mallinckrodt (GBR), Novartis AG, and others.